...
机译:基于前白型和淋巴细胞的预后评分,一种预测长期存活的新工具,阶段的长期存活率是阶段的胃癌
Huazhong Univ Sci &
Technol Tongji Hosp Tongji Med Coll Dept Oncol Wuhan 430030 Hubei Peoples R China;
Cent S Univ Hunan Canc Hosp Dept Gastroenterol &
Urol Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Cent S Univ Dept Gastroduodenal &
Pancreat Surg Hunan Canc Hosp Changsha 410013 Hunan Peoples R China;
Prealbumin; Albumin; Lymphocytes; Survival; Gastric cancer;
机译:基于前白型和淋巴细胞的预后评分,一种预测长期存活的新工具,阶段的长期存活率是阶段的胃癌
机译:胃癌根治性切除术后的复发预测:意大利胃癌研究小组(GIRCG)预后评分系统的外部验证
机译:基于白蛋白前蛋白/ CRP的预后评分,可预测无法手术的胃癌患者转移的新工具
机译:多抗民切除后胃癌的预后分数
机译:预测结肠直肠癌患者的生存:多基因生存率的发展和验证
机译:术前控制营养状况(CONUT)评分可作为根治性切除术后II期至III期胃癌辅助化疗后长期预后的指标
机译:基于序列性和淋巴细胞的预后评分,一种新的工具,用于预测阶段II / III胃癌患者的治疗切除后的长期存活